Oxidized linoleic acid metabolites (OLAMs) are a class of endogenous transient receptor potential vanilloid 1 (TRPV1) channel agonists released on exposure of tissue to transient noxious temperatures. These lipid compounds also contribute to inflammatory and heat allodynia. Because persistent pain after a burn injury represents a significant clinical challenge for treatment, we developed an in vivo rat model of partial-thickness cutaneous thermal injury and examined whether TRPV1 and specific OLAM metabolites play a role in mediating postburn pain injury. This peripheral model of burn injury had marked thermal allodynia peaking at 24 h after thermal injury, with allodynia being maintained for up to 7 d. Immunohistochemical characterization of tissue taken from injury sites revealed an increase in leukocyte/macrophage infiltration that was colocalized with TRPV1-positive fibers. Using this peripheral thermal injury model, we found that pharmacological blockade of peripheral TRPV1 receptors reduced thermal allodynia by about 98%. Moreover, there was a significant increase in OLAM levels compared to naive controls in hind paw skin biopsies. Additional studies of the metabolism of [C 14 ]-linoleic acid in skin biopsies revealed the role of the cytochrome P450 (CYP) system in mediating the metabolism of linoleic acid after thermal injury. Finally, we demonstrated that direct inhibition of OLAMs using OLAM antibodies and indirect inhibition using the CYP inhibitor ketoconazole significantly reduced postburn thermal allodynia. Collectively, these findings point to a novel role of the OLAMs and CYP-related enzymes in generating postburn allodynia via activation of peripheral TRPV1. Ó
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Introduction
Although the mechanisms of postburn pain are incompletely understood, recent research has shed light on one potentially important receptor system. Transient receptor potential vanilloid 1 (TRPV1), a prominent member of the transient receptor potential (TRP) family of ion channels, plays a critical role in detecting various noxious physical and chemical stimuli, including noxious heat, and contributing to inflammatory heat hyperalgesia [2, 30] . Although prior studies have implicated TRPV1 in mediating thermal allodynia in the first 60 m after thermal injury, the mechanism of activation is unclear [1] .
Recent studies have characterized a novel class of endogenous TRPV1 agonists, consisting of 9-hydroxy-10E and 13-hydroxy-10E, 12Z-octadecadienoic acid (9-HODE and 13-HODE) as well their metabolites, 9-oxoODE and 13-oxoODE. These oxidized linoleic acid metabolites (OLAMs) are released upon transient thermal stimulation and prolonged inflammatory tissue injury, where they activate TRPV1 and contribute to thermal allodynia [22, 23, 25] . The mechanism of the formation of OLAMs includes enzymatic oxidative pathways such as the cytochrome P450 (CYP) class of enzymes [5, 26] . It is interesting that previous studies have demonstrated that oxidized forms of linoleic acid and arachidonic acid are elevated after burn injury. These oxidized lipids have been found in burned tissue extracts [5, 6, 27] and circulating in the vascular compartment [4, 11, 20] . However, to our knowledge, no study has evaluated whether OLAMs contribute to postburn pain.
Burn injuries trigger a distinct constellation of pain mechanisms. Preclinical studies indicate that burn injuries invoke both inflammatory and neuropathic pain mechanisms [15] as well as central changes, including a rapid downregulation in expression of mu opioid receptors [29] . Because of this unusual phenotype and the continued poor clinical outcomes in treating burn pain in patients [7, 21] , it is important to determine the mechanisms of postburn pain using a highly reproducible preclinical model. Here we present a peripheral model of partial-thickness cutaneous
